Saffron: Sources, Dosing, and Safety

Saffron threads, the dried red stigmas of the crocus
Saffron threads, the dried red stigmas of the crocus
Real saffron slowly tinting water golden-yellow
Real saffron slowly tinting water golden-yellow
Freshly picked crocus flowers; about 150 make a gram
Freshly picked crocus flowers; about 150 make a gram

Saffron is the most expensive spice in the world — each flower yields only three red stigmas, and it takes roughly 150,000 flowers, all hand-picked, to make a single kilogram. That extraordinary value creates two practical problems this page covers. First, because saffron is so costly, it is one of the most heavily adulterated foods on Earth: what is sold may be bulked, dyed, or entirely fake. Second, while normal amounts are very safe, saffron is not harmless in large doses, and it carries a real pregnancy caution. This page covers the dose used in the clinical trials (about 30 mg per day), how real saffron is told apart from fake, and what the research shows about its safety limits.


Table of Contents

  1. The World's Most Expensive Spice
  2. Crocin, Picrocrocin, Safranal, and Grading
  3. The Adulteration Problem
  4. Signs of Fake or Low-Grade Saffron
  5. Doses Used in Trials: About 30 mg a Day
  6. Forms: Threads, Powder, and Extracts
  7. Safety and High-Dose Toxicity
  8. Pregnancy and Who the Research Raises Concerns For
  9. Drug Interactions
  10. Quality Checks in Brief
  11. Key Research Papers
  12. Connections
  13. Featured Videos

The World's Most Expensive Spice

Saffron is the dried red stigma of Crocus sativus, a sterile autumn-flowering crocus that must be propagated by hand from corms. Each purple flower produces just three thread-like crimson stigmas, and those threads must be plucked individually, usually within hours of the flower opening. The result is a spice that trades by the gram and routinely sells for more than its weight in silver. The main producers are Iran (by far the largest, at roughly 90 percent of world supply), followed by regions of Spain, India (Kashmir), Afghanistan, Greece, and Morocco.

None of this matters for cooking a paella — a pinch is a pinch. It matters enormously for anyone buying saffron as a supplement, because the economics of a spice this valuable create overwhelming incentives to cheat, and because the difference between a strong, genuine product and a weak or fake one can be the difference between the dose used in the trials and no active compound at all.

Back to Table of Contents

Crocin, Picrocrocin, Safranal, and Grading

Saffron's quality is defined by three families of molecules, each responsible for one sensory property:

The international standard ISO 3632 grades saffron by measuring these three by spectrophotometry: coloring strength (crocins, read near 440 nm), bitterness (picrocrocin, near 257 nm), and aroma (safranal, near 330 nm). Higher coloring strength earns a higher category (Category I is the top grade). When a supplement is standardized — guaranteeing, say, a minimum percentage of crocins or a set amount of safranal per capsule — it is these same markers being pinned down, which is why standardized extracts gave the reproducible results seen in the depression trials.

Back to Table of Contents

The Adulteration Problem

Saffron's price makes it a perennial target for fraud — it has been adulterated for centuries, and modern food-quality studies (such as Mena-García and colleagues, 2023) still routinely find diluted or mislabeled products on the market. Common tricks include:

The consequence for a supplement buyer is twofold: an adulterated product may deliver far less active compound than the label implies, and some adulterants (certain synthetic dyes) are undesirable to consume. This is why sourcing is not a side issue — it directly determines whether a product delivers anything like the studied dose.

Back to Table of Contents

Signs of Fake or Low-Grade Saffron

No home test is definitive, but a few practical checks catch most crude fakes:

Back to Table of Contents

Doses Used in Trials: About 30 mg a Day

The great convenience of saffron research is how consistent the dose has been:

In short: 30 mg per day of a standardized product is the dose used in the mood and premenstrual trials, and about 20 mg per day in the eye research; the benefits reported were at these doses, not higher ones. Culinary use in food is far below these amounts and is simply a flavoring, not a therapeutic dose.

Back to Table of Contents

Forms: Threads, Powder, and Extracts

Crocin and safranal degrade with exposure to light and heat, which is why saffron is kept in an airtight container away from both; a beautiful thread that has sat in a sunny rack for years may be far weaker than a fresh, well-stored one.

Back to Table of Contents

Safety and High-Dose Toxicity

At the doses used in research, saffron has a reassuring safety record. In a formal safety evaluation, Modaghegh and colleagues (2008) gave healthy volunteers saffron tablets (up to 400 mg per day for a week) and found no clinically important adverse effects on blood counts or biochemistry, and Mohamadpour and colleagues (2013) reported similar tolerability for crocin tablets. The mild side effects sometimes reported at supplement doses include nausea, headache, reduced appetite, and drowsiness.

The picture changes at much higher doses. Toxicology reviews such as Bostan and colleagues (2017) describe saffron as safe at the doses used in trials. One summary table in that review lists nausea, vomiting, diarrhea, and bleeding with saffron intakes of 1.2 to 2 grams; most of its other toxicity figures come from animal studies, such as an oral LD50 (the dose that kills half the test animals) of about 4,120 mg of saffron extract per kg of body weight in mice. A 2012 review by Poma and colleagues describes doses above 5 grams a day as a pregnancy hazard because of saffron's uterine-stimulating activity. These are enormous amounts compared with the 30 mg dose used in trials — more than a hundred-fold higher — and they are why "megadosing" saffron is a hazard rather than merely wasteful.

Back to Table of Contents

Pregnancy and Who the Research Raises Concerns For

Back to Table of Contents

Drug Interactions

Back to Table of Contents

Quality Checks in Brief

The quality points in brief:

Back to Table of Contents

Key Research Papers

  1. Modaghegh MH, Shahabian M, Esmaeili HA, et al. (2008). Safety evaluation of saffron (Crocus sativus) tablets in healthy volunteers. Phytomedicine — PubMed PMID: 18693099
  2. Mohamadpour AH, Ayati Z, Parizadeh MR, et al. (2013). Safety evaluation of crocin (a constituent of saffron) tablets in healthy volunteers. Iranian Journal of Basic Medical Sciences — PubMed PMID: 23638291
  3. Bostan HB, Mehri S, Hosseinzadeh H (2017). Toxicology effects of saffron and its constituents: a review. Iranian Journal of Basic Medical Sciences — PubMed PMID: 28293386
  4. Schmidt M, Betti G, Hensel A (2007). Saffron in phytotherapy: pharmacology and clinical uses. Wiener Medizinische Wochenschrift — PubMed PMID: 17704979
  5. Mena-García A, Sanz ML, Díez-Municio M, Ruiz-Matute AI (2023). A combined gas and liquid chromatographic approach for quality evaluation of saffron-based food supplements. Foods — PubMed PMID: 38002129
  6. Moratalla-López N, Bagur MJ, Lorenzo C, et al. (2019). Bioactivity and bioavailability of the major metabolites of Crocus sativus L. flower. Molecules — PubMed PMID: 31382514
  7. José Bagur M, Alonso Salinas GL, Jiménez-Monreal AM, et al. (2018). Saffron: an old medicinal plant and a potential novel functional food. Molecules — PubMed PMID: 29295497
  8. Christodoulou E, Kadoglou NP, Kostomitsopoulos N, Valsami G (2015). Saffron: a natural product with potential pharmaceutical applications. Journal of Pharmacy and Pharmacology — PubMed PMID: 26272123
  9. Bathaei P, et al. (2025). Effects of Crocus sativus and its active constituents on cytochrome P450: a review. Naunyn-Schmiedeberg's Archives of Pharmacology — PubMed PMID: 40167627
  10. Hausenblas HA, Saha D, Dubyak PJ, Anton SD (2013). Saffron (Crocus sativus L.) and major depressive disorder: a meta-analysis of randomized clinical trials. Journal of Integrative Medicine — PubMed PMID: 24299602
  11. Poma A, Fontecchio G, Carlucci G, Chichiriccò G (2012). Anti-inflammatory properties of drugs from saffron crocus. Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry — PubMed PMID: 22934747

PubMed Topic Searches

  1. PubMed: Saffron safety and toxicity
  2. PubMed: Saffron adulteration and authentication
  3. PubMed: Crocin and safranal bioavailability
  4. PubMed: Saffron and pregnancy
  5. PubMed: Saffron drug interactions

Back to Table of Contents

External Authoritative Resources

Back to Table of Contents

Connections

Back to Table of Contents